Navigation Links
Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013
Date:5/20/2013

MINNEAPOLIS, May 20, 2013 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI) announced today that it will release financial results for the fiscal fourth quarter and full year ended March 31, 2013 at the market close on Thursday, May 30, 2013. The Company will host a conference call and webcast to discuss these results on Thursday, May 30, 2013 at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). Individuals wishing to participate in the conference call should dial 888-549-7750, no passcode is necessary. To access the live webcast of the call, go to Uroplasty's website at www.uroplasty.com and click on Investor Relations. 

An audio replay will be available for 30 days following the call at 800-406-7325 with the passcode 4618943#.
An archived webcast will also be available at www.uroplasty.com

About Uroplasty, Inc. Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a global medical company committed to offering transformative treatment options to specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.Contact Information:Uroplasty, Inc. 

EVC Group Medi Jiwani, Vice President, CFO, and Treasurer

Jenifer Kirtland (Investors) 952.426.6140

415.568.9349Amy Phillips (Media)412-327-9499
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty Announces CEO Resignation
2. Uroplasty To Present At The 25th Annual ROTH Growth Stock Conference
3. Uroplasty Announces Executive Changes In US Sales Organization
4. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
5. Uroplasty To Participate In The Oppenheimer 23rd Annual Healthcare Conference
6. Uroplasty To Participate In Two Upcoming Investor Conferences
7. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
8. Uroplasty To Participate In Two Upcoming Conferences
9. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
10. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
11. Uroplasty To Present At The JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... latest in wound care advancements to physician colleagues, skilled nursing facility medical directors ... "Navigating the Treacherous Waters of Wound Care." , "At many of these conferences ...
Breaking Medicine News(10 mins):